Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.44 |
| ▸ | CDC25B | P30305 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8082488 | 1.00 | ALOX15 (1.00) | ALOX15MEN1CYP3A4KMT2ALMNA | |
| SCHEMBL21429 | 1.00 | ALOX15 (1.00) | ALOX15MEN1CYP3A4KMT2ALMNA | |
| SCHEMBL29659795 | 1.00 | ALOX15 (1.00) | ALOX15MEN1CYP3A4KMT2ALMNA | |
| SCHEMBL4437129 | 1.00 | ALOX15 (1.00) | ALOX15MEN1CYP3A4KMT2ALMNA | |
| SCHEMBL8079400 | 1.00 | ALOX15 (1.00) | ALOX15MEN1CYP3A4KMT2ALMNA | |
| SCHEMBL15824175 | 1.00 | ALOX15 (1.00) | ALOX15MEN1CYP3A4KMT2ALMNA | |
| Alcohol SCHEMBL11523426 | 0.95 | ALOX15 (0.90) | ALOX15MEN1CYP3A4KMT2ALMNA | |
| SCHEMBL722489 | 0.92 | ALOX15 (0.85) | ALOX15MEN1CYP3A4KMT2ALMNA | |
| SCHEMBL30492702 | 0.92 | ALOX15 (0.85) | ALOX15MEN1CYP3A4KMT2ALMNA | |
| SCHEMBL28826305 | 0.90 | ALOX15 (0.81) | ALOX15MEN1CYP3A4KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109970533-B | (6R,10R) -6,10, 14-trimethylpentadecan-2-one prepared from (R) -6,10, 14-trimethylpentadeca-5-en-2-one | 帝斯曼知识产权资产管理有限公司 | 2022-06-14 | — | — | CN | claimed |
| EP-2935177-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10-DIMETYLUNDEC-5-EN-2-ONE OR 6,10-DIMETYLUNDECA-5,9-DIEN-2-ONE | DSM IP ASSETS BV (NL) | 2019-07-24 | — | — | EP | claimed |
| EP-2935185-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10,14-TRIMETYLPENTADECA-5,9,13-TRIEN-2-ONE OR 6,10,14-TRIMETYLPENTADECA-5,9-DIEN-2-ONE | DSM IP ASSETS BV (NL) | 2019-02-20 | — | — | EP | claimed |
| EP-2935181-B1 | EFFICIENT PROCESS OF ASYMMETRIC HYDROGENATION OF UNSATURATED KETONES USING ADDITIVES | DSM IP ASSETS BV (NL) | 2019-01-30 | — | — | EP | claimed |
| EP-2935233-B1 | PROCESS OF ASYMMETRIC HYDROGENATION OF KETALS AND ACETALS | DSM IP ASSETS BV (NL) | 2019-01-30 | — | — | EP | claimed |
| EP-2935175-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-6,10,14-TRIMETYLPENTADEC-5-EN-2-ONE | DSM IP ASSETS BV (NL) | 2018-09-19 | — | — | EP | claimed |
| EP-2935190-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10-DIMETYLUNDECA-3,5,9-TRIEN-2-ONE | DSM IP ASSETS BV (NL) | 2018-09-19 | — | — | EP | claimed |
| EP-2935176-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | claimed |
| EP-2935191-B1 | PREPARATION OF (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE FROM 3,7-DIMETYLOCT-2-ENAL OR 3,7-DIMETYLOCTA-2,6-DIENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | claimed |
| US-9611200-B2 | (6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10,14 trimetylpentadeca-5,9,13-trien-2-one or 6,10,14-trimetylpentadeca-5,9-dien-2-one | DSM IP ASSETS B.V. (NL) | 2017-04-04 | — | — | US | claimed |
| US-9452961-B2 | (6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one | DSM IP ASSETS B.V. (NL) | 2016-09-27 | — | — | US | claimed |
| US-20160185683-A1 | PROCESS OF ASYMMETRIC HYDROGENATION OF KETALS AND ACETALS | DSM IP ASSETS B.V. (NL) | 2016-06-30 | — | — | US | claimed |
| US-20150329457-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10-DIMETYLUNDEC-5-EN-2-ONE OR 6,10-DIMETYLUNDECA-5,9-DIEN-2-ONE | DSM IP ASSETS B.V. (NL) | 2015-11-19 | — | — | US | claimed |
| US-20150329456-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10,14 TRIMETYLPENTADECA-5,9,13-TRIEN-2-ONE OR 6,10,14-TRIMETYLPENTADECA-5,9-DIEN-2-ONE | DSM IP ASSETS B.V. (NL) | 2015-11-19 | — | — | US | claimed |
| US-20150321971-A1 | EFFICIENT PROCESS OF ASYMMETRIC HYDROGENATION OF UNSATURATED KETONES USING ADDITIVES | DSM IP ASSETS B.V. (NL) | 2015-11-12 | — | — | US | claimed |
| CN-109970533-B | (6R,10R) -6,10, 14-trimethylpentadecan-2-one prepared from (R) -6,10, 14-trimethylpentadeca-5-en-2-one | 帝斯曼知识产权资产管理有限公司 | 2022-06-14 | — | — | CN | disclosed |
| EP-2935177-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10-DIMETYLUNDEC-5-EN-2-ONE OR 6,10-DIMETYLUNDECA-5,9-DIEN-2-ONE | DSM IP ASSETS BV (NL) | 2019-07-24 | — | — | EP | disclosed |
| US-20150329457-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10-DIMETYLUNDEC-5-EN-2-ONE OR 6,10-DIMETYLUNDECA-5,9-DIEN-2-ONE | DSM IP ASSETS B.V. (NL) | 2015-11-19 | — | — | US | disclosed |
| US-20150321971-A1 | EFFICIENT PROCESS OF ASYMMETRIC HYDROGENATION OF UNSATURATED KETONES USING ADDITIVES | DSM IP ASSETS B.V. (NL) | 2015-11-12 | — | — | US | disclosed |
| US-20150321986-A1 | USING MIXTURES OF E/Z ISOMERS TO OBTAIN QUANTITATIVELY SPECIFIC PRODUCTS BY COMBINED ASYMMETRIC HYDROGENATIONS | DSM IP ASSETS B.V. (NL) | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329456-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10,14 TRIMETYLPENTADECA-5,9,13-TRIEN-2-ONE OR 6,10,14-TRIMETYLPENTADECA-5,9-DIEN-2-ONE | CYP3A5, ADRA1D, HTR5A | ALOX15 756/4885MEN1 3261/4885CYP3A4 81/4885 |
| US-20150321971-A1 | EFFICIENT PROCESS OF ASYMMETRIC HYDROGENATION OF UNSATURATED KETONES USING ADDITIVES | ADH5, ADH1A, ADH1C | ALOX15 171/4885MEN1 4403/4885CYP3A4 386/4885 |
| US-20150321986-A1 | USING MIXTURES OF E/Z ISOMERS TO OBTAIN QUANTITATIVELY SPECIFIC PRODUCTS BY COMBINED ASYMMETRIC HYDROGENATIONS | EPHX2, HBZ, ELOVL5 | ALOX15 104/4885MEN1 1465/4885CYP3A4 247/4885 |
| US-20160185683-A1 | PROCESS OF ASYMMETRIC HYDROGENATION OF KETALS AND ACETALS | KAT5, AKR1D1, AKR1C2 | ALOX15 177/4885MEN1 3222/4885CYP3A4 1268/4885 |
| US-20150329457-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10-DIMETYLUNDEC-5-EN-2-ONE OR 6,10-DIMETYLUNDECA-5,9-DIEN-2-ONE | PDE12, CYP2D6, PDE9A | ALOX15 731/4885MEN1 1634/4885CYP3A4 111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.